nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—CYP1A2—Dacarbazine—muscle cancer	0.0269	0.671	CbGbCtD
Tizanidine—NISCH—Podofilox—Etoposide—muscle cancer	0.0219	0.592	CbGdCrCtD
Tizanidine—NISCH—Vinblastine—Vincristine—muscle cancer	0.0151	0.408	CbGdCrCtD
Tizanidine—CYP1A2—Etoposide—muscle cancer	0.0132	0.328	CbGbCtD
Tizanidine—Oedema—Vincristine—muscle cancer	0.00189	0.00205	CcSEcCtD
Tizanidine—Infection—Vincristine—muscle cancer	0.00188	0.00204	CcSEcCtD
Tizanidine—Phlebitis—Doxorubicin—muscle cancer	0.00188	0.00203	CcSEcCtD
Tizanidine—Nervous system disorder—Vincristine—muscle cancer	0.00186	0.00201	CcSEcCtD
Tizanidine—Thrombocytopenia—Vincristine—muscle cancer	0.00185	0.00201	CcSEcCtD
Tizanidine—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00185	0.00201	CcSEcCtD
Tizanidine—Hyperhidrosis—Vincristine—muscle cancer	0.00183	0.00198	CcSEcCtD
Tizanidine—Fatigue—Dactinomycin—muscle cancer	0.00183	0.00198	CcSEcCtD
Tizanidine—Back pain—Etoposide—muscle cancer	0.00182	0.00197	CcSEcCtD
Tizanidine—Vascular purpura—Doxorubicin—muscle cancer	0.00181	0.00196	CcSEcCtD
Tizanidine—Muscle spasms—Etoposide—muscle cancer	0.00181	0.00196	CcSEcCtD
Tizanidine—Hepatic failure—Doxorubicin—muscle cancer	0.0018	0.00195	CcSEcCtD
Tizanidine—Eye pain—Doxorubicin—muscle cancer	0.00179	0.00194	CcSEcCtD
Tizanidine—Mood swings—Methotrexate—muscle cancer	0.00177	0.00192	CcSEcCtD
Tizanidine—Hypotension—Vincristine—muscle cancer	0.00177	0.00192	CcSEcCtD
Tizanidine—Renal failure acute—Doxorubicin—muscle cancer	0.00175	0.0019	CcSEcCtD
Tizanidine—Feeling abnormal—Dactinomycin—muscle cancer	0.00175	0.00189	CcSEcCtD
Tizanidine—Ill-defined disorder—Etoposide—muscle cancer	0.00174	0.00189	CcSEcCtD
Tizanidine—Anaemia—Etoposide—muscle cancer	0.00174	0.00188	CcSEcCtD
Tizanidine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00173	0.00188	CcSEcCtD
Tizanidine—Liver function test abnormal—Methotrexate—muscle cancer	0.00172	0.00187	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00172	0.00187	CcSEcCtD
Tizanidine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00171	0.00186	CcSEcCtD
Tizanidine—Paraesthesia—Vincristine—muscle cancer	0.0017	0.00184	CcSEcCtD
Tizanidine—Malaise—Etoposide—muscle cancer	0.00169	0.00184	CcSEcCtD
Tizanidine—Vertigo—Etoposide—muscle cancer	0.00169	0.00183	CcSEcCtD
Tizanidine—Leukopenia—Etoposide—muscle cancer	0.00168	0.00182	CcSEcCtD
Tizanidine—Purpura—Doxorubicin—muscle cancer	0.00168	0.00182	CcSEcCtD
Tizanidine—Abdominal pain—Dactinomycin—muscle cancer	0.00167	0.00181	CcSEcCtD
Tizanidine—Body temperature increased—Dactinomycin—muscle cancer	0.00167	0.00181	CcSEcCtD
Tizanidine—Cardiac failure—Doxorubicin—muscle cancer	0.00166	0.0018	CcSEcCtD
Tizanidine—Loss of consciousness—Etoposide—muscle cancer	0.00165	0.00179	CcSEcCtD
Tizanidine—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00165	0.00179	CcSEcCtD
Tizanidine—Fatigue—Vincristine—muscle cancer	0.00163	0.00177	CcSEcCtD
Tizanidine—Convulsion—Etoposide—muscle cancer	0.00163	0.00176	CcSEcCtD
Tizanidine—Hyponatraemia—Doxorubicin—muscle cancer	0.00162	0.00176	CcSEcCtD
Tizanidine—Hypertension—Etoposide—muscle cancer	0.00162	0.00176	CcSEcCtD
Tizanidine—Constipation—Vincristine—muscle cancer	0.00162	0.00175	CcSEcCtD
Tizanidine—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00162	0.00175	CcSEcCtD
Tizanidine—Asthma—Methotrexate—muscle cancer	0.00161	0.00175	CcSEcCtD
Tizanidine—Affect lability—Doxorubicin—muscle cancer	0.00159	0.00173	CcSEcCtD
Tizanidine—Migraine—Doxorubicin—muscle cancer	0.00159	0.00173	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00159	0.00172	CcSEcCtD
Tizanidine—Discomfort—Etoposide—muscle cancer	0.00158	0.00171	CcSEcCtD
Tizanidine—Hypersensitivity—Dactinomycin—muscle cancer	0.00156	0.00169	CcSEcCtD
Tizanidine—Gastrointestinal pain—Vincristine—muscle cancer	0.00155	0.00168	CcSEcCtD
Tizanidine—Confusional state—Etoposide—muscle cancer	0.00155	0.00167	CcSEcCtD
Tizanidine—Cardiac arrest—Doxorubicin—muscle cancer	0.00154	0.00167	CcSEcCtD
Tizanidine—Anaphylactic shock—Etoposide—muscle cancer	0.00153	0.00166	CcSEcCtD
Tizanidine—Mood swings—Doxorubicin—muscle cancer	0.00153	0.00166	CcSEcCtD
Tizanidine—Infection—Etoposide—muscle cancer	0.00152	0.00165	CcSEcCtD
Tizanidine—Asthenia—Dactinomycin—muscle cancer	0.00152	0.00165	CcSEcCtD
Tizanidine—Thrombocytopenia—Etoposide—muscle cancer	0.0015	0.00163	CcSEcCtD
Tizanidine—Tachycardia—Etoposide—muscle cancer	0.0015	0.00162	CcSEcCtD
Tizanidine—Abdominal pain—Vincristine—muscle cancer	0.0015	0.00162	CcSEcCtD
Tizanidine—Body temperature increased—Vincristine—muscle cancer	0.0015	0.00162	CcSEcCtD
Tizanidine—Liver function test abnormal—Doxorubicin—muscle cancer	0.00149	0.00162	CcSEcCtD
Tizanidine—Skin disorder—Etoposide—muscle cancer	0.00149	0.00161	CcSEcCtD
Tizanidine—Dry skin—Doxorubicin—muscle cancer	0.00148	0.00161	CcSEcCtD
Tizanidine—Hyperhidrosis—Etoposide—muscle cancer	0.00148	0.00161	CcSEcCtD
Tizanidine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00148	0.0016	CcSEcCtD
Tizanidine—Hypokalaemia—Doxorubicin—muscle cancer	0.00147	0.0016	CcSEcCtD
Tizanidine—Diarrhoea—Dactinomycin—muscle cancer	0.00145	0.00157	CcSEcCtD
Tizanidine—Pneumonia—Methotrexate—muscle cancer	0.00145	0.00157	CcSEcCtD
Tizanidine—Drowsiness—Methotrexate—muscle cancer	0.00144	0.00156	CcSEcCtD
Tizanidine—Depression—Methotrexate—muscle cancer	0.00144	0.00156	CcSEcCtD
Tizanidine—Hypotension—Etoposide—muscle cancer	0.00143	0.00155	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00143	0.00155	CcSEcCtD
Tizanidine—Muscular weakness—Doxorubicin—muscle cancer	0.00143	0.00155	CcSEcCtD
Tizanidine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00143	0.00155	CcSEcCtD
Tizanidine—Renal failure—Methotrexate—muscle cancer	0.00142	0.00153	CcSEcCtD
Tizanidine—Conjunctivitis—Methotrexate—muscle cancer	0.0014	0.00152	CcSEcCtD
Tizanidine—Influenza—Doxorubicin—muscle cancer	0.0014	0.00152	CcSEcCtD
Tizanidine—Dysphagia—Doxorubicin—muscle cancer	0.0014	0.00152	CcSEcCtD
Tizanidine—Asthma—Doxorubicin—muscle cancer	0.0014	0.00152	CcSEcCtD
Tizanidine—Hypersensitivity—Vincristine—muscle cancer	0.00139	0.00151	CcSEcCtD
Tizanidine—Sweating—Methotrexate—muscle cancer	0.00138	0.0015	CcSEcCtD
Tizanidine—Paraesthesia—Etoposide—muscle cancer	0.00138	0.00149	CcSEcCtD
Tizanidine—Haematuria—Methotrexate—muscle cancer	0.00137	0.00149	CcSEcCtD
Tizanidine—Dyspnoea—Etoposide—muscle cancer	0.00137	0.00148	CcSEcCtD
Tizanidine—Somnolence—Etoposide—muscle cancer	0.00136	0.00148	CcSEcCtD
Tizanidine—Angina pectoris—Doxorubicin—muscle cancer	0.00136	0.00148	CcSEcCtD
Tizanidine—Hepatobiliary disease—Methotrexate—muscle cancer	0.00136	0.00148	CcSEcCtD
Tizanidine—Asthenia—Vincristine—muscle cancer	0.00136	0.00147	CcSEcCtD
Tizanidine—Vomiting—Dactinomycin—muscle cancer	0.00135	0.00146	CcSEcCtD
Tizanidine—Bronchitis—Doxorubicin—muscle cancer	0.00134	0.00146	CcSEcCtD
Tizanidine—Agranulocytosis—Methotrexate—muscle cancer	0.00134	0.00146	CcSEcCtD
Tizanidine—Rash—Dactinomycin—muscle cancer	0.00134	0.00145	CcSEcCtD
Tizanidine—Fatigue—Etoposide—muscle cancer	0.00132	0.00143	CcSEcCtD
Tizanidine—Constipation—Etoposide—muscle cancer	0.00131	0.00142	CcSEcCtD
Tizanidine—Haemoglobin—Methotrexate—muscle cancer	0.0013	0.00141	CcSEcCtD
Tizanidine—Diarrhoea—Vincristine—muscle cancer	0.00129	0.0014	CcSEcCtD
Tizanidine—Haemorrhage—Methotrexate—muscle cancer	0.00129	0.0014	CcSEcCtD
Tizanidine—Hepatitis—Methotrexate—muscle cancer	0.00129	0.0014	CcSEcCtD
Tizanidine—Pollakiuria—Doxorubicin—muscle cancer	0.00129	0.0014	CcSEcCtD
Tizanidine—Pharyngitis—Methotrexate—muscle cancer	0.00128	0.00139	CcSEcCtD
Tizanidine—Urinary tract disorder—Methotrexate—muscle cancer	0.00128	0.00138	CcSEcCtD
Tizanidine—Urethral disorder—Methotrexate—muscle cancer	0.00127	0.00137	CcSEcCtD
Tizanidine—Weight decreased—Doxorubicin—muscle cancer	0.00127	0.00137	CcSEcCtD
Tizanidine—Feeling abnormal—Etoposide—muscle cancer	0.00126	0.00137	CcSEcCtD
Tizanidine—Hyperglycaemia—Doxorubicin—muscle cancer	0.00126	0.00137	CcSEcCtD
Tizanidine—Nausea—Dactinomycin—muscle cancer	0.00126	0.00136	CcSEcCtD
Tizanidine—Pneumonia—Doxorubicin—muscle cancer	0.00125	0.00136	CcSEcCtD
Tizanidine—Gastrointestinal pain—Etoposide—muscle cancer	0.00125	0.00136	CcSEcCtD
Tizanidine—Dizziness—Vincristine—muscle cancer	0.00125	0.00136	CcSEcCtD
Tizanidine—Drowsiness—Doxorubicin—muscle cancer	0.00125	0.00135	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00124	0.00134	CcSEcCtD
Tizanidine—Renal failure—Doxorubicin—muscle cancer	0.00123	0.00133	CcSEcCtD
Tizanidine—Erythema multiforme—Methotrexate—muscle cancer	0.00122	0.00132	CcSEcCtD
Tizanidine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00122	0.00132	CcSEcCtD
Tizanidine—Urticaria—Etoposide—muscle cancer	0.00122	0.00132	CcSEcCtD
Tizanidine—Jaundice—Doxorubicin—muscle cancer	0.00122	0.00132	CcSEcCtD
Tizanidine—Body temperature increased—Etoposide—muscle cancer	0.00121	0.00131	CcSEcCtD
Tizanidine—Abdominal pain—Etoposide—muscle cancer	0.00121	0.00131	CcSEcCtD
Tizanidine—Conjunctivitis—Doxorubicin—muscle cancer	0.00121	0.00131	CcSEcCtD
Tizanidine—Tinnitus—Methotrexate—muscle cancer	0.00121	0.00131	CcSEcCtD
Tizanidine—Vomiting—Vincristine—muscle cancer	0.0012	0.0013	CcSEcCtD
Tizanidine—Cardiac disorder—Methotrexate—muscle cancer	0.0012	0.0013	CcSEcCtD
Tizanidine—Sweating—Doxorubicin—muscle cancer	0.0012	0.0013	CcSEcCtD
Tizanidine—Rash—Vincristine—muscle cancer	0.00119	0.00129	CcSEcCtD
Tizanidine—Dermatitis—Vincristine—muscle cancer	0.00119	0.00129	CcSEcCtD
Tizanidine—Haematuria—Doxorubicin—muscle cancer	0.00119	0.00129	CcSEcCtD
Tizanidine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00118	0.00128	CcSEcCtD
Tizanidine—Angiopathy—Methotrexate—muscle cancer	0.00117	0.00127	CcSEcCtD
Tizanidine—Sinusitis—Doxorubicin—muscle cancer	0.00117	0.00127	CcSEcCtD
Tizanidine—Immune system disorder—Methotrexate—muscle cancer	0.00117	0.00127	CcSEcCtD
Tizanidine—Mediastinal disorder—Methotrexate—muscle cancer	0.00116	0.00126	CcSEcCtD
Tizanidine—Agranulocytosis—Doxorubicin—muscle cancer	0.00116	0.00126	CcSEcCtD
Tizanidine—Alopecia—Methotrexate—muscle cancer	0.00114	0.00124	CcSEcCtD
Tizanidine—Bradycardia—Doxorubicin—muscle cancer	0.00114	0.00123	CcSEcCtD
Tizanidine—Mental disorder—Methotrexate—muscle cancer	0.00113	0.00123	CcSEcCtD
Tizanidine—Hypersensitivity—Etoposide—muscle cancer	0.00113	0.00122	CcSEcCtD
Tizanidine—Haemoglobin—Doxorubicin—muscle cancer	0.00112	0.00122	CcSEcCtD
Tizanidine—Nausea—Vincristine—muscle cancer	0.00112	0.00122	CcSEcCtD
Tizanidine—Rhinitis—Doxorubicin—muscle cancer	0.00112	0.00122	CcSEcCtD
Tizanidine—Haemorrhage—Doxorubicin—muscle cancer	0.00112	0.00121	CcSEcCtD
Tizanidine—Hepatitis—Doxorubicin—muscle cancer	0.00112	0.00121	CcSEcCtD
Tizanidine—Pharyngitis—Doxorubicin—muscle cancer	0.00111	0.0012	CcSEcCtD
Tizanidine—Urinary tract disorder—Doxorubicin—muscle cancer	0.00111	0.0012	CcSEcCtD
Tizanidine—Asthenia—Etoposide—muscle cancer	0.0011	0.00119	CcSEcCtD
Tizanidine—Connective tissue disorder—Doxorubicin—muscle cancer	0.0011	0.00119	CcSEcCtD
Tizanidine—Urethral disorder—Doxorubicin—muscle cancer	0.0011	0.00119	CcSEcCtD
Tizanidine—Back pain—Methotrexate—muscle cancer	0.00109	0.00118	CcSEcCtD
Tizanidine—Pruritus—Etoposide—muscle cancer	0.00108	0.00118	CcSEcCtD
Tizanidine—Vision blurred—Methotrexate—muscle cancer	0.00106	0.00115	CcSEcCtD
Tizanidine—Erythema multiforme—Doxorubicin—muscle cancer	0.00106	0.00115	CcSEcCtD
Tizanidine—Diarrhoea—Etoposide—muscle cancer	0.00105	0.00114	CcSEcCtD
Tizanidine—Ill-defined disorder—Methotrexate—muscle cancer	0.00104	0.00113	CcSEcCtD
Tizanidine—Tinnitus—Doxorubicin—muscle cancer	0.00104	0.00113	CcSEcCtD
Tizanidine—Anaemia—Methotrexate—muscle cancer	0.00104	0.00113	CcSEcCtD
Tizanidine—Cardiac disorder—Doxorubicin—muscle cancer	0.00104	0.00113	CcSEcCtD
Tizanidine—Angiopathy—Doxorubicin—muscle cancer	0.00102	0.0011	CcSEcCtD
Tizanidine—Malaise—Methotrexate—muscle cancer	0.00101	0.0011	CcSEcCtD
Tizanidine—Dizziness—Etoposide—muscle cancer	0.00101	0.0011	CcSEcCtD
Tizanidine—Immune system disorder—Doxorubicin—muscle cancer	0.00101	0.0011	CcSEcCtD
Tizanidine—Vertigo—Methotrexate—muscle cancer	0.00101	0.0011	CcSEcCtD
Tizanidine—Mediastinal disorder—Doxorubicin—muscle cancer	0.00101	0.00109	CcSEcCtD
Tizanidine—Leukopenia—Methotrexate—muscle cancer	0.00101	0.00109	CcSEcCtD
Tizanidine—Arrhythmia—Doxorubicin—muscle cancer	0.001	0.00108	CcSEcCtD
Tizanidine—Alopecia—Doxorubicin—muscle cancer	0.000989	0.00107	CcSEcCtD
Tizanidine—Mental disorder—Doxorubicin—muscle cancer	0.000981	0.00106	CcSEcCtD
Tizanidine—Convulsion—Methotrexate—muscle cancer	0.000975	0.00106	CcSEcCtD
Tizanidine—Vomiting—Etoposide—muscle cancer	0.000975	0.00106	CcSEcCtD
Tizanidine—Rash—Etoposide—muscle cancer	0.000967	0.00105	CcSEcCtD
Tizanidine—Dermatitis—Etoposide—muscle cancer	0.000966	0.00105	CcSEcCtD
Tizanidine—Flatulence—Doxorubicin—muscle cancer	0.00096	0.00104	CcSEcCtD
Tizanidine—Arthralgia—Methotrexate—muscle cancer	0.000958	0.00104	CcSEcCtD
Tizanidine—Tension—Doxorubicin—muscle cancer	0.000956	0.00104	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000951	0.00103	CcSEcCtD
Tizanidine—Discomfort—Methotrexate—muscle cancer	0.000946	0.00103	CcSEcCtD
Tizanidine—Nervousness—Doxorubicin—muscle cancer	0.000946	0.00103	CcSEcCtD
Tizanidine—Back pain—Doxorubicin—muscle cancer	0.000942	0.00102	CcSEcCtD
Tizanidine—Muscle spasms—Doxorubicin—muscle cancer	0.000937	0.00101	CcSEcCtD
Tizanidine—Confusional state—Methotrexate—muscle cancer	0.000926	0.001	CcSEcCtD
Tizanidine—Anaphylactic shock—Methotrexate—muscle cancer	0.000918	0.000995	CcSEcCtD
Tizanidine—Vision blurred—Doxorubicin—muscle cancer	0.000918	0.000995	CcSEcCtD
Tizanidine—Infection—Methotrexate—muscle cancer	0.000912	0.000988	CcSEcCtD
Tizanidine—Nausea—Etoposide—muscle cancer	0.000911	0.000987	CcSEcCtD
Tizanidine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000904	0.000979	CcSEcCtD
Tizanidine—Nervous system disorder—Methotrexate—muscle cancer	0.000901	0.000976	CcSEcCtD
Tizanidine—Anaemia—Doxorubicin—muscle cancer	0.000901	0.000976	CcSEcCtD
Tizanidine—Thrombocytopenia—Methotrexate—muscle cancer	0.000899	0.000974	CcSEcCtD
Tizanidine—Agitation—Doxorubicin—muscle cancer	0.000895	0.00097	CcSEcCtD
Tizanidine—Skin disorder—Methotrexate—muscle cancer	0.000892	0.000966	CcSEcCtD
Tizanidine—Hyperhidrosis—Methotrexate—muscle cancer	0.000888	0.000962	CcSEcCtD
Tizanidine—Malaise—Doxorubicin—muscle cancer	0.000879	0.000952	CcSEcCtD
Tizanidine—Vertigo—Doxorubicin—muscle cancer	0.000875	0.000948	CcSEcCtD
Tizanidine—Syncope—Doxorubicin—muscle cancer	0.000874	0.000947	CcSEcCtD
Tizanidine—Leukopenia—Doxorubicin—muscle cancer	0.000872	0.000945	CcSEcCtD
Tizanidine—Hypotension—Methotrexate—muscle cancer	0.000858	0.00093	CcSEcCtD
Tizanidine—Loss of consciousness—Doxorubicin—muscle cancer	0.000856	0.000928	CcSEcCtD
Tizanidine—Convulsion—Doxorubicin—muscle cancer	0.000844	0.000915	CcSEcCtD
Tizanidine—Hypertension—Doxorubicin—muscle cancer	0.000841	0.000911	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000837	0.000907	CcSEcCtD
Tizanidine—Arthralgia—Doxorubicin—muscle cancer	0.000829	0.000899	CcSEcCtD
Tizanidine—Anxiety—Doxorubicin—muscle cancer	0.000827	0.000896	CcSEcCtD
Tizanidine—Paraesthesia—Methotrexate—muscle cancer	0.000825	0.000893	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000824	0.000893	CcSEcCtD
Tizanidine—Discomfort—Doxorubicin—muscle cancer	0.00082	0.000888	CcSEcCtD
Tizanidine—Dyspnoea—Methotrexate—muscle cancer	0.000819	0.000887	CcSEcCtD
Tizanidine—Somnolence—Methotrexate—muscle cancer	0.000816	0.000885	CcSEcCtD
Tizanidine—Dry mouth—Doxorubicin—muscle cancer	0.000811	0.000879	CcSEcCtD
Tizanidine—Dyspepsia—Methotrexate—muscle cancer	0.000808	0.000876	CcSEcCtD
Tizanidine—Confusional state—Doxorubicin—muscle cancer	0.000802	0.000869	CcSEcCtD
Tizanidine—Oedema—Doxorubicin—muscle cancer	0.000795	0.000862	CcSEcCtD
Tizanidine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000795	0.000862	CcSEcCtD
Tizanidine—Fatigue—Methotrexate—muscle cancer	0.000792	0.000858	CcSEcCtD
Tizanidine—Infection—Doxorubicin—muscle cancer	0.00079	0.000856	CcSEcCtD
Tizanidine—Shock—Doxorubicin—muscle cancer	0.000782	0.000848	CcSEcCtD
Tizanidine—Nervous system disorder—Doxorubicin—muscle cancer	0.00078	0.000845	CcSEcCtD
Tizanidine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000779	0.000844	CcSEcCtD
Tizanidine—Tachycardia—Doxorubicin—muscle cancer	0.000776	0.000841	CcSEcCtD
Tizanidine—Skin disorder—Doxorubicin—muscle cancer	0.000772	0.000837	CcSEcCtD
Tizanidine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000769	0.000833	CcSEcCtD
Tizanidine—Feeling abnormal—Methotrexate—muscle cancer	0.000757	0.00082	CcSEcCtD
Tizanidine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000751	0.000814	CcSEcCtD
Tizanidine—Hypotension—Doxorubicin—muscle cancer	0.000743	0.000805	CcSEcCtD
Tizanidine—Urticaria—Methotrexate—muscle cancer	0.00073	0.00079	CcSEcCtD
Tizanidine—Abdominal pain—Methotrexate—muscle cancer	0.000726	0.000787	CcSEcCtD
Tizanidine—Body temperature increased—Methotrexate—muscle cancer	0.000726	0.000787	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000724	0.000785	CcSEcCtD
Tizanidine—Paraesthesia—Doxorubicin—muscle cancer	0.000714	0.000774	CcSEcCtD
Tizanidine—Dyspnoea—Doxorubicin—muscle cancer	0.000709	0.000768	CcSEcCtD
Tizanidine—Somnolence—Doxorubicin—muscle cancer	0.000707	0.000766	CcSEcCtD
Tizanidine—Dyspepsia—Doxorubicin—muscle cancer	0.0007	0.000758	CcSEcCtD
Tizanidine—Fatigue—Doxorubicin—muscle cancer	0.000686	0.000743	CcSEcCtD
Tizanidine—Constipation—Doxorubicin—muscle cancer	0.00068	0.000737	CcSEcCtD
Tizanidine—Hypersensitivity—Methotrexate—muscle cancer	0.000677	0.000733	CcSEcCtD
Tizanidine—Asthenia—Methotrexate—muscle cancer	0.000659	0.000714	CcSEcCtD
Tizanidine—Feeling abnormal—Doxorubicin—muscle cancer	0.000655	0.00071	CcSEcCtD
Tizanidine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00065	0.000705	CcSEcCtD
Tizanidine—Pruritus—Methotrexate—muscle cancer	0.00065	0.000704	CcSEcCtD
Tizanidine—Urticaria—Doxorubicin—muscle cancer	0.000632	0.000684	CcSEcCtD
Tizanidine—Abdominal pain—Doxorubicin—muscle cancer	0.000629	0.000681	CcSEcCtD
Tizanidine—Body temperature increased—Doxorubicin—muscle cancer	0.000629	0.000681	CcSEcCtD
Tizanidine—Diarrhoea—Methotrexate—muscle cancer	0.000628	0.000681	CcSEcCtD
Tizanidine—Dizziness—Methotrexate—muscle cancer	0.000607	0.000658	CcSEcCtD
Tizanidine—Hypersensitivity—Doxorubicin—muscle cancer	0.000586	0.000635	CcSEcCtD
Tizanidine—Vomiting—Methotrexate—muscle cancer	0.000584	0.000633	CcSEcCtD
Tizanidine—Rash—Methotrexate—muscle cancer	0.000579	0.000627	CcSEcCtD
Tizanidine—Dermatitis—Methotrexate—muscle cancer	0.000578	0.000627	CcSEcCtD
Tizanidine—Asthenia—Doxorubicin—muscle cancer	0.000571	0.000618	CcSEcCtD
Tizanidine—Pruritus—Doxorubicin—muscle cancer	0.000563	0.00061	CcSEcCtD
Tizanidine—Nausea—Methotrexate—muscle cancer	0.000545	0.000591	CcSEcCtD
Tizanidine—Diarrhoea—Doxorubicin—muscle cancer	0.000544	0.000589	CcSEcCtD
Tizanidine—Dizziness—Doxorubicin—muscle cancer	0.000526	0.00057	CcSEcCtD
Tizanidine—Vomiting—Doxorubicin—muscle cancer	0.000506	0.000548	CcSEcCtD
Tizanidine—Rash—Doxorubicin—muscle cancer	0.000501	0.000543	CcSEcCtD
Tizanidine—Dermatitis—Doxorubicin—muscle cancer	0.000501	0.000543	CcSEcCtD
Tizanidine—Nausea—Doxorubicin—muscle cancer	0.000472	0.000512	CcSEcCtD
